MoonLake Immunotherapeutics (MLTX) has 7 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 6 sales totalling $5.2M. Most recent filing: July 29, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| July 29, 2026 filed July 27, 2026 | Reich Kristian Chief Scientific Officer | −$22,000 | 1,100 | −0% | Yes | |
|
|
||||||
| July 23, 2026 filed July 21, 2026 | Reich Kristian Chief Scientific Officer | −$1,049,960 | 52,448 | −2% | Yes | |
|
|
||||||
| July 21, 2026 filed July 20, 2026 | Reich Kristian Chief Scientific Officer | −$877,933 | 43,700 | −2% | Yes | |
|
|
||||||
| July 20, 2026 filed July 15, 2026 | Reich Kristian Chief Scientific Officer | −$322,261 | 16,105 | −1% | Yes | |
|
|
||||||
| July 13, 2026 filed July 9, 2026 | Santos da Silva Jorge Chief Executive Officer | −$2,046,205 | 102,225 | −4% | Yes | |
|
|
||||||
Showing the 5 most recent of 7 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free